Topic
Bengaluru pharma
News
19 May 2026
Strides Pharma delivers strong FY26 performance with 50% PAT growth, ex‑US markets up 21%
Strides Pharma Science Ltd. reported a robust FY26 performance, with consolidated EBITDA rising to ₹9,253 crore and operational profit after…
News
29 Apr 2026
Dr. Reddy’s Semaglutide Injection Wins Health Canada Approval with OneSource as CDMO Partner
OneSource Specialty Pharma Limited (BSE: 544292, NSE: ONESOURCE) announced that partner Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE:…